

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 5.64819004 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.64819004 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.64819004 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.64819004 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.64819004 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.64819004 |
| 7 | oligosaccharide catabolic process (GO:0009313) | 5.26518407 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 4.82134281 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.75442424 |
| 10 | response to peptidoglycan (GO:0032494) | 4.69855865 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.65960732 |
| 12 | low-density lipoprotein particle clearance (GO:0034383) | 4.34793614 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.26544069 |
| 14 | ceramide catabolic process (GO:0046514) | 4.22835594 |
| 15 | keratan sulfate catabolic process (GO:0042340) | 4.14498458 |
| 16 | amino sugar catabolic process (GO:0046348) | 4.03315718 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 3.81558493 |
| 18 | microglial cell activation (GO:0001774) | 3.74891205 |
| 19 | substrate-dependent cell migration (GO:0006929) | 3.73164044 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.67942115 |
| 21 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.67461475 |
| 22 | apoptotic cell clearance (GO:0043277) | 3.65305681 |
| 23 | positive regulation of leukocyte degranulation (GO:0043302) | 3.65140831 |
| 24 | membrane lipid catabolic process (GO:0046466) | 3.63717737 |
| 25 | N-acetylneuraminate metabolic process (GO:0006054) | 3.61065157 |
| 26 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.59494346 |
| 27 | cell adhesion mediated by integrin (GO:0033627) | 3.57831967 |
| 28 | T-helper 1 type immune response (GO:0042088) | 3.57718500 |
| 29 | protein localization to endosome (GO:0036010) | 3.57007197 |
| 30 | phagocytosis, recognition (GO:0006910) | 3.55123185 |
| 31 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.48482191 |
| 32 | regulation of cholesterol storage (GO:0010885) | 3.39666026 |
| 33 | barbed-end actin filament capping (GO:0051016) | 3.39304562 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.38959843 |
| 35 | collagen fibril organization (GO:0030199) | 3.38292467 |
| 36 | response to host immune response (GO:0052572) | 3.37531387 |
| 37 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37531387 |
| 38 | basement membrane organization (GO:0071711) | 3.37133159 |
| 39 | collagen catabolic process (GO:0030574) | 3.35248606 |
| 40 | regulation of mononuclear cell migration (GO:0071675) | 3.34050274 |
| 41 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.33947732 |
| 42 | sphingolipid catabolic process (GO:0030149) | 3.33382158 |
| 43 | collagen metabolic process (GO:0032963) | 3.32940949 |
| 44 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.32222234 |
| 45 | protein heterotrimerization (GO:0070208) | 3.31210453 |
| 46 | monocyte chemotaxis (GO:0002548) | 3.29433643 |
| 47 | axon extension involved in axon guidance (GO:0048846) | 3.28380240 |
| 48 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.28380240 |
| 49 | dermatan sulfate biosynthetic process (GO:0030208) | 3.27637011 |
| 50 | response to host (GO:0075136) | 3.26986122 |
| 51 | response to host defenses (GO:0052200) | 3.26986122 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.26986122 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.23328479 |
| 54 | regulation of monocyte chemotaxis (GO:0090025) | 3.20860912 |
| 55 | cellular response to arsenic-containing substance (GO:0071243) | 3.19320380 |
| 56 | regulation of podosome assembly (GO:0071801) | 3.18851986 |
| 57 | pinocytosis (GO:0006907) | 3.15930009 |
| 58 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.15415141 |
| 59 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.15198259 |
| 60 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.14800032 |
| 61 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.14569616 |
| 62 | regulation of mast cell degranulation (GO:0043304) | 3.14138844 |
| 63 | positive regulation of mast cell activation (GO:0033005) | 3.12926589 |
| 64 | positive regulation of cholesterol efflux (GO:0010875) | 3.11973180 |
| 65 | dermatan sulfate metabolic process (GO:0030205) | 3.10192356 |
| 66 | positive regulation of macrophage cytokine production (GO:0060907) | 3.09447110 |
| 67 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.08342635 |
| 68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.08268158 |
| 69 | positive regulation of mast cell degranulation (GO:0043306) | 3.08268158 |
| 70 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.07277848 |
| 71 | multicellular organismal catabolic process (GO:0044243) | 3.06946360 |
| 72 | L-amino acid import (GO:0043092) | 3.04898257 |
| 73 | semaphorin-plexin signaling pathway (GO:0071526) | 3.04884720 |
| 74 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.04631933 |
| 75 | adenosine receptor signaling pathway (GO:0001973) | 3.03603701 |
| 76 | regulation of leukocyte degranulation (GO:0043300) | 3.03538899 |
| 77 | cellular extravasation (GO:0045123) | 3.02056685 |
| 78 | cortical actin cytoskeleton organization (GO:0030866) | 2.97049331 |
| 79 | multicellular organismal metabolic process (GO:0044236) | 2.96468402 |
| 80 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.95652948 |
| 81 | wound healing, spreading of epidermal cells (GO:0035313) | 2.95352727 |
| 82 | negative regulation of lipid storage (GO:0010888) | 2.93885740 |
| 83 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.93285811 |
| 84 | glycosphingolipid catabolic process (GO:0046479) | 2.91831818 |
| 85 | macrophage activation (GO:0042116) | 2.91268682 |
| 86 | osteoclast differentiation (GO:0030316) | 2.90550036 |
| 87 | positive regulation of interferon-alpha production (GO:0032727) | 2.89864451 |
| 88 | endodermal cell differentiation (GO:0035987) | 2.89260045 |
| 89 | immunoglobulin mediated immune response (GO:0016064) | 2.88465615 |
| 90 | amino acid import (GO:0043090) | 2.88018547 |
| 91 | response to lipoprotein particle (GO:0055094) | 2.87958817 |
| 92 | I-kappaB phosphorylation (GO:0007252) | 2.86529875 |
| 93 | regulation of vitamin metabolic process (GO:0030656) | 2.86370946 |
| 94 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.85350596 |
| 95 | hyaluronan catabolic process (GO:0030214) | 2.83374961 |
| 96 | mannose metabolic process (GO:0006013) | 2.83312880 |
| 97 | regulation of macrophage cytokine production (GO:0010935) | 2.83000782 |
| 98 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.80922918 |
| 99 | germinal center formation (GO:0002467) | 2.80261119 |
| 100 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.79670569 |
| 101 | glomerular filtration (GO:0003094) | 2.78210768 |
| 102 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.78130655 |
| 103 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.78130489 |
| 104 | eosinophil chemotaxis (GO:0048245) | 2.76314571 |
| 105 | chondroitin sulfate catabolic process (GO:0030207) | 2.75844504 |
| 106 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.75256377 |
| 107 | extracellular matrix disassembly (GO:0022617) | 2.74857179 |
| 108 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.74574843 |
| 109 | detection of external biotic stimulus (GO:0098581) | 2.74535186 |
| 110 | positive regulation of bone remodeling (GO:0046852) | 2.73496673 |
| 111 | positive regulation of bone resorption (GO:0045780) | 2.73496673 |
| 112 | glial cell migration (GO:0008347) | 2.70939202 |
| 113 | peptide catabolic process (GO:0043171) | 2.70710744 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.70467471 |
| 115 | regulation of macrophage chemotaxis (GO:0010758) | 2.70379789 |
| 116 | regulation of mast cell activation (GO:0033003) | 2.69933690 |
| 117 | regulation of chemokine biosynthetic process (GO:0045073) | 2.69931607 |
| 118 | macrophage differentiation (GO:0030225) | 2.69268489 |
| 119 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.69081207 |
| 120 | myeloid dendritic cell differentiation (GO:0043011) | 2.67919036 |
| 121 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.67891009 |
| 122 | germ cell migration (GO:0008354) | 2.67088596 |
| 123 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.66834970 |
| 124 | decidualization (GO:0046697) | 2.64921209 |
| 125 | cellular response to lipopolysaccharide (GO:0071222) | 2.64053114 |
| 126 | virion attachment to host cell (GO:0019062) | 2.64013395 |
| 127 | adhesion of symbiont to host cell (GO:0044650) | 2.64013395 |
| 128 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.63771305 |
| 129 | positive regulation of extracellular matrix organization (GO:1903055) | 2.63169250 |
| 130 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.60392354 |
| 131 | positive regulation of sterol transport (GO:0032373) | 2.60177457 |
| 132 | positive regulation of cholesterol transport (GO:0032376) | 2.60177457 |
| 133 | NIK/NF-kappaB signaling (GO:0038061) | 2.60024454 |
| 134 | negative regulation of interleukin-17 production (GO:0032700) | 2.59474147 |
| 135 | negative regulation of granulocyte differentiation (GO:0030853) | 2.59398894 |
| 136 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.59057136 |
| 137 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.59055906 |
| 138 | cortical cytoskeleton organization (GO:0030865) | 2.58406262 |
| 139 | regulation of early endosome to late endosome transport (GO:2000641) | 2.58108840 |
| 140 | cellular response to molecule of bacterial origin (GO:0071219) | 2.57925905 |
| 141 | granulocyte activation (GO:0036230) | 2.57296657 |
| 142 | positive regulation of p38MAPK cascade (GO:1900745) | 2.56781151 |
| 143 | response to fluid shear stress (GO:0034405) | 2.56320187 |
| 144 | lipoprotein transport (GO:0042953) | 2.56027382 |
| 145 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.55016238 |
| 146 | stress fiber assembly (GO:0043149) | 2.54091444 |
| 147 | myeloid cell activation involved in immune response (GO:0002275) | 2.54087679 |
| 148 | positive regulation of interleukin-6 production (GO:0032755) | 2.53685683 |
| 149 | response to laminar fluid shear stress (GO:0034616) | 2.53629888 |
| 150 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.53538856 |
| 151 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.53216990 |
| 152 | positive regulation of heat generation (GO:0031652) | 2.53161858 |
| 153 | fibroblast migration (GO:0010761) | 2.52869477 |
| 154 | response to muramyl dipeptide (GO:0032495) | 2.52581685 |
| 155 | glycolipid catabolic process (GO:0019377) | 2.52359740 |
| 156 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.51352647 |
| 157 | regulation of smooth muscle cell migration (GO:0014910) | 2.50404471 |
| 158 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49020685 |
| 159 | negative regulation of mast cell activation (GO:0033004) | 2.48521110 |
| 160 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.47885079 |
| 161 | import into cell (GO:0098657) | 2.47173960 |
| 162 | renal filtration (GO:0097205) | 2.45961434 |
| 163 | positive regulation of antigen processing and presentation (GO:0002579) | 2.43550640 |
| 164 | chondrocyte proliferation (GO:0035988) | 2.43324602 |
| 165 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.43182511 |
| 166 | ovulation from ovarian follicle (GO:0001542) | 2.42942388 |
| 167 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.42193909 |
| 168 | phagocytosis, engulfment (GO:0006911) | 2.39211794 |
| 169 | glycoprotein catabolic process (GO:0006516) | 2.38734065 |
| 170 | response to thyroid hormone (GO:0097066) | 2.38730689 |
| 171 | iron ion import (GO:0097286) | 2.38606691 |
| 172 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.37985052 |
| 173 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.37921114 |
| 174 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.37181921 |
| 175 | negative regulation of phagocytosis (GO:0050765) | 2.34536728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.73563211 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.70167826 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.64190538 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.44250144 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.13451554 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.09780132 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.98349023 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62348972 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50611765 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.40914003 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.33881217 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.31602479 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.31547743 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27509610 |
| 15 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.24906516 |
| 16 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.18435526 |
| 17 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.17887539 |
| 18 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.17157364 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15150050 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14695059 |
| 21 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.13549725 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.13070305 |
| 23 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07842123 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06592889 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03564500 |
| 26 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.00577164 |
| 27 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.00577164 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99749761 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.99574207 |
| 30 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.92076420 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.83813837 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.78714010 |
| 33 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.78645002 |
| 34 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.76622429 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75670998 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74072211 |
| 37 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.64487600 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.63508416 |
| 39 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63346024 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.62996602 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62962641 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.62908555 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62197758 |
| 44 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.53542350 |
| 45 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.52384533 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52358653 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51849621 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51189297 |
| 49 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.50644664 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50198535 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48364771 |
| 52 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.46288043 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44913806 |
| 54 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44020961 |
| 55 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43145381 |
| 56 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.42419086 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41682255 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41670741 |
| 59 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40943151 |
| 60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40578524 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.39250325 |
| 62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38621020 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.37552071 |
| 64 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.36597162 |
| 65 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36346023 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35920421 |
| 67 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.33414658 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.32856383 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31672256 |
| 70 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.31342506 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30944055 |
| 72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30823013 |
| 73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28266872 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27098336 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25913298 |
| 76 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.24795434 |
| 77 | RXR_22108803_ChIP-Seq_LS180_Human | 1.24722577 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24312343 |
| 79 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21405851 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19991001 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19625121 |
| 82 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19200959 |
| 83 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18939828 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18593283 |
| 85 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17393331 |
| 86 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17393331 |
| 87 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15942857 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15518556 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14612553 |
| 90 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14533185 |
| 91 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.13688054 |
| 92 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12532173 |
| 93 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12487540 |
| 94 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11176958 |
| 95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.10014815 |
| 96 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09001321 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08832905 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08465133 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08333467 |
| 100 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.08021152 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07964300 |
| 102 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06058471 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04941824 |
| 104 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04389786 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02169428 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02075653 |
| 107 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01991420 |
| 108 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01533085 |
| 109 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01006676 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00595650 |
| 111 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00162688 |
| 112 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98984581 |
| 113 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98920335 |
| 114 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98584459 |
| 115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98533801 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97404480 |
| 117 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96964672 |
| 118 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95610812 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95342659 |
| 120 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95131668 |
| 121 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94660170 |
| 122 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91735682 |
| 123 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.89931052 |
| 124 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.88657367 |
| 125 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.88511027 |
| 126 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88275160 |
| 127 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87872275 |
| 128 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87872275 |
| 129 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.87866126 |
| 130 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.87478964 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87108931 |
| 132 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86679909 |
| 133 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.84847415 |
| 134 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84325990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.26587810 |
| 2 | MP0005257_abnormal_intraocular_pressure | 4.07565341 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.96573535 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.39089851 |
| 5 | MP0005275_abnormal_skin_tensile | 3.04675691 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.02583579 |
| 7 | MP0005503_abnormal_tendon_morphology | 2.77983982 |
| 8 | MP0004272_abnormal_basement_membrane | 2.66906141 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.56892455 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.48193788 |
| 11 | MP0003690_abnormal_glial_cell | 2.40702211 |
| 12 | MP0001958_emphysema | 2.33046663 |
| 13 | MP0003279_aneurysm | 2.27799205 |
| 14 | MP0003303_peritoneal_inflammation | 2.16664060 |
| 15 | MP0006082_CNS_inflammation | 2.14823729 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.11856154 |
| 17 | MP0009785_altered_susceptibility_to | 2.08651588 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.07252082 |
| 19 | MP0004185_abnormal_adipocyte_glucose | 2.06166366 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.01755836 |
| 21 | MP0002254_reproductive_system_inflammat | 1.97934908 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.95301627 |
| 23 | MP0002877_abnormal_melanocyte_morpholog | 1.92526323 |
| 24 | MP0006054_spinal_hemorrhage | 1.91508965 |
| 25 | MP0005387_immune_system_phenotype | 1.90819312 |
| 26 | MP0001790_abnormal_immune_system | 1.90819312 |
| 27 | MP0005623_abnormal_meninges_morphology | 1.79607607 |
| 28 | MP0000685_abnormal_immune_system | 1.78236841 |
| 29 | MP0005451_abnormal_body_composition | 1.75887744 |
| 30 | MP0002998_abnormal_bone_remodeling | 1.73417950 |
| 31 | MP0005671_abnormal_response_to | 1.73188508 |
| 32 | MP0005025_abnormal_response_to | 1.70576098 |
| 33 | MP0009764_decreased_sensitivity_to | 1.69435201 |
| 34 | MP0009384_cardiac_valve_regurgitation | 1.68878326 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.67954530 |
| 36 | MP0005171_absent_coat_pigmentation | 1.67908129 |
| 37 | MP0004130_abnormal_muscle_cell | 1.66725459 |
| 38 | MP0001853_heart_inflammation | 1.61583473 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.61203321 |
| 40 | MP0001879_abnormal_lymphatic_vessel | 1.59995056 |
| 41 | MP0003091_abnormal_cell_migration | 1.55623591 |
| 42 | MP0002419_abnormal_innate_immunity | 1.54525734 |
| 43 | MP0005670_abnormal_white_adipose | 1.52595504 |
| 44 | MP0003329_amyloid_beta_deposits | 1.50704446 |
| 45 | MP0000343_altered_response_to | 1.49590792 |
| 46 | MP0003436_decreased_susceptibility_to | 1.49037782 |
| 47 | MP0005310_abnormal_salivary_gland | 1.46434828 |
| 48 | MP0004947_skin_inflammation | 1.42382849 |
| 49 | MP0002723_abnormal_immune_serum | 1.42024514 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.40800670 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.38226541 |
| 52 | MP0008004_abnormal_stomach_pH | 1.37585278 |
| 53 | MP0000767_abnormal_smooth_muscle | 1.35014453 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.34014515 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.34014515 |
| 56 | MP0005508_abnormal_skeleton_morphology | 1.33520879 |
| 57 | MP0005023_abnormal_wound_healing | 1.33277544 |
| 58 | MP0000733_abnormal_muscle_development | 1.32896002 |
| 59 | MP0005390_skeleton_phenotype | 1.30315853 |
| 60 | MP0002405_respiratory_system_inflammati | 1.28848009 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 1.28802251 |
| 62 | MP0009840_abnormal_foam_cell | 1.26311162 |
| 63 | MP0004134_abnormal_chest_morphology | 1.25654848 |
| 64 | MP0009278_abnormal_bone_marrow | 1.25301727 |
| 65 | MP0000604_amyloidosis | 1.25250330 |
| 66 | MP0008469_abnormal_protein_level | 1.24624289 |
| 67 | MP0003448_altered_tumor_morphology | 1.20723418 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.19505004 |
| 69 | MP0001800_abnormal_humoral_immune | 1.19301104 |
| 70 | MP0002090_abnormal_vision | 1.18726502 |
| 71 | MP0001819_abnormal_immune_cell | 1.17104160 |
| 72 | MP0002420_abnormal_adaptive_immunity | 1.16559458 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.16541875 |
| 74 | MP0000371_diluted_coat_color | 1.16243723 |
| 75 | MP0004858_abnormal_nervous_system | 1.16063271 |
| 76 | MP0005375_adipose_tissue_phenotype | 1.10630371 |
| 77 | MP0010155_abnormal_intestine_physiology | 1.10574632 |
| 78 | MP0005197_abnormal_uvea_morphology | 1.09776555 |
| 79 | MP0000920_abnormal_myelination | 1.08731111 |
| 80 | MP0002933_joint_inflammation | 1.08669723 |
| 81 | MP0003724_increased_susceptibility_to | 1.08536126 |
| 82 | MP0010307_abnormal_tumor_latency | 1.08485514 |
| 83 | MP0005164_abnormal_response_to | 1.05926190 |
| 84 | MP0003385_abnormal_body_wall | 1.04323491 |
| 85 | MP0001299_abnormal_eye_distance/ | 1.03738151 |
| 86 | MP0003828_pulmonary_edema | 1.03383197 |
| 87 | MP0005165_increased_susceptibility_to | 1.03010661 |
| 88 | MP0005464_abnormal_platelet_physiology | 1.01342159 |
| 89 | MP0005076_abnormal_cell_differentiation | 1.00220899 |
| 90 | MP0001915_intracranial_hemorrhage | 0.99960320 |
| 91 | MP0008260_abnormal_autophagy | 0.99946112 |
| 92 | MP0001851_eye_inflammation | 0.99032633 |
| 93 | MP0002115_abnormal_skeleton_extremities | 0.98883811 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.98469258 |
| 95 | MP0003045_fibrosis | 0.98041719 |
| 96 | MP0003634_abnormal_glial_cell | 0.97556939 |
| 97 | MP0002060_abnormal_skin_morphology | 0.97435293 |
| 98 | MP0009115_abnormal_fat_cell | 0.96074539 |
| 99 | MP0005595_abnormal_vascular_smooth | 0.95121054 |
| 100 | MP0002108_abnormal_muscle_morphology | 0.93714862 |
| 101 | MP0002113_abnormal_skeleton_development | 0.93613144 |
| 102 | MP0001835_abnormal_antigen_presentation | 0.93094956 |
| 103 | MP0009250_abnormal_appendicular_skeleto | 0.92686323 |
| 104 | MP0004510_myositis | 0.92590391 |
| 105 | MP0002896_abnormal_bone_mineralization | 0.92526440 |
| 106 | MP0003795_abnormal_bone_structure | 0.88972139 |
| 107 | MP0001849_ear_inflammation | 0.88946744 |
| 108 | MP0003806_abnormal_nucleotide_metabolis | 0.87004078 |
| 109 | MP0002133_abnormal_respiratory_system | 0.85279638 |
| 110 | MP0005388_respiratory_system_phenotype | 0.85279638 |
| 111 | MP0001614_abnormal_blood_vessel | 0.83770260 |
| 112 | MP0005000_abnormal_immune_tolerance | 0.83598872 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.83385184 |
| 114 | MP0001542_abnormal_bone_strength | 0.82638356 |
| 115 | MP0003075_altered_response_to | 0.81214668 |
| 116 | MP0001243_abnormal_dermal_layer | 0.80688614 |
| 117 | MP0000163_abnormal_cartilage_morphology | 0.78665174 |
| 118 | MP0005365_abnormal_bile_salt | 0.78228951 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.77811506 |
| 120 | MP0002282_abnormal_trachea_morphology | 0.76918677 |
| 121 | MP0009763_increased_sensitivity_to | 0.76778337 |
| 122 | MP0002452_abnormal_antigen_presenting | 0.76404405 |
| 123 | MP0010234_abnormal_vibrissa_follicle | 0.75463811 |
| 124 | MP0004883_abnormal_blood_vessel | 0.74924857 |
| 125 | MP0003195_calcinosis | 0.74843970 |
| 126 | MP0000249_abnormal_blood_vessel | 0.74634263 |
| 127 | MP0000858_altered_metastatic_potential | 0.74476813 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.74302193 |
| 129 | MP0002168_other_aberrant_phenotype | 0.73999112 |
| 130 | MP0001175_abnormal_lung_morphology | 0.72515365 |
| 131 | MP0000716_abnormal_immune_system | 0.72352221 |
| 132 | MP0005647_abnormal_sex_gland | 0.72010708 |
| 133 | MP0002128_abnormal_blood_circulation | 0.71146742 |
| 134 | MP0003183_abnormal_peptide_metabolism | 0.68692242 |
| 135 | MP0010352_gastrointestinal_tract_polyps | 0.67606646 |
| 136 | MP0005193_abnormal_anterior_eye | 0.67440445 |
| 137 | MP0009053_abnormal_anal_canal | 0.66752732 |
| 138 | MP0002148_abnormal_hypersensitivity_rea | 0.65982101 |
| 139 | MP0000013_abnormal_adipose_tissue | 0.65349041 |
| 140 | MP0004019_abnormal_vitamin_homeostasis | 0.64900067 |
| 141 | MP0005166_decreased_susceptibility_to | 0.64509204 |
| 142 | MP0003011_delayed_dark_adaptation | 0.63659741 |
| 143 | MP0000428_abnormal_craniofacial_morphol | 0.62672213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.70821813 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.63920183 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.54330371 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.50519142 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.25544124 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.25544124 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.25544124 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 4.17384972 |
| 9 | Cerebral aneurysm (HP:0004944) | 4.16115619 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.11238861 |
| 11 | Neurofibrillary tangles (HP:0002185) | 4.08892611 |
| 12 | Aortic dissection (HP:0002647) | 3.92924925 |
| 13 | Mutism (HP:0002300) | 3.62859273 |
| 14 | Disinhibition (HP:0000734) | 3.61288516 |
| 15 | Arterial tortuosity (HP:0005116) | 3.51526738 |
| 16 | Mucopolysacchariduria (HP:0008155) | 3.42302544 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.42302544 |
| 18 | Ankle contracture (HP:0006466) | 3.36241305 |
| 19 | Shallow orbits (HP:0000586) | 3.30112104 |
| 20 | Aortic aneurysm (HP:0004942) | 3.28619191 |
| 21 | Vascular tortuosity (HP:0004948) | 3.27117503 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.25224207 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.24597561 |
| 24 | Soft skin (HP:0000977) | 3.23657984 |
| 25 | Nuclear cataract (HP:0100018) | 3.23192036 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.21402683 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.21402683 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.21402683 |
| 29 | Broad metatarsal (HP:0001783) | 3.11511946 |
| 30 | Axonal loss (HP:0003447) | 3.08536986 |
| 31 | Spondylolisthesis (HP:0003302) | 3.04861385 |
| 32 | Cerebral inclusion bodies (HP:0100314) | 3.04553431 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 3.03119470 |
| 34 | Vertebral compression fractures (HP:0002953) | 2.94897973 |
| 35 | Cervical subluxation (HP:0003308) | 2.90374286 |
| 36 | Mediastinal lymphadenopathy (HP:0100721) | 2.90035858 |
| 37 | Mitral valve prolapse (HP:0001634) | 2.84230270 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.78559169 |
| 39 | Dilatation of the ascending aorta (HP:0005111) | 2.69955058 |
| 40 | Complement deficiency (HP:0004431) | 2.64593094 |
| 41 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.64046932 |
| 42 | Myocardial infarction (HP:0001658) | 2.63106880 |
| 43 | Agnosia (HP:0010524) | 2.62650223 |
| 44 | Eczematoid dermatitis (HP:0000976) | 2.58910927 |
| 45 | Striae distensae (HP:0001065) | 2.56351581 |
| 46 | Metaphyseal irregularity (HP:0003025) | 2.54022665 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.52335315 |
| 48 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51963986 |
| 49 | Recurrent bacterial skin infections (HP:0005406) | 2.50550144 |
| 50 | Hematochezia (HP:0002573) | 2.49635246 |
| 51 | Blue sclerae (HP:0000592) | 2.46202618 |
| 52 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45993380 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.45993380 |
| 54 | Purpura (HP:0000979) | 2.45794565 |
| 55 | Loss of speech (HP:0002371) | 2.45075369 |
| 56 | Bladder diverticulum (HP:0000015) | 2.43705313 |
| 57 | Peritonitis (HP:0002586) | 2.38330678 |
| 58 | Disproportionate tall stature (HP:0001519) | 2.37298601 |
| 59 | Abnormality of the periventricular white matter (HP:0002518) | 2.34577465 |
| 60 | Atrophic scars (HP:0001075) | 2.31912625 |
| 61 | Ovoid vertebral bodies (HP:0003300) | 2.31241396 |
| 62 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.23149417 |
| 63 | Abnormality of the lumbar spine (HP:0100712) | 2.22164426 |
| 64 | Orchitis (HP:0100796) | 2.20168527 |
| 65 | Follicular hyperkeratosis (HP:0007502) | 2.19849071 |
| 66 | Tetraparesis (HP:0002273) | 2.19336256 |
| 67 | Genu recurvatum (HP:0002816) | 2.18893072 |
| 68 | Abnormality of complement system (HP:0005339) | 2.18881071 |
| 69 | Dementia (HP:0000726) | 2.13793569 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.12312368 |
| 71 | Glomerulonephritis (HP:0000099) | 2.11624827 |
| 72 | Peripheral demyelination (HP:0011096) | 2.10382806 |
| 73 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.09947530 |
| 74 | Progressive neurologic deterioration (HP:0002344) | 2.09858260 |
| 75 | J-shaped sella turcica (HP:0002680) | 2.08489279 |
| 76 | Fragile skin (HP:0001030) | 2.07518258 |
| 77 | Broad ribs (HP:0000885) | 2.07379943 |
| 78 | Global brain atrophy (HP:0002283) | 2.04267505 |
| 79 | Amyloidosis (HP:0011034) | 2.04227273 |
| 80 | Abnormality of the frontal sinuses (HP:0002687) | 2.03998825 |
| 81 | Gingivitis (HP:0000230) | 2.03559477 |
| 82 | Increased CSF protein (HP:0002922) | 2.03276584 |
| 83 | Increased serum ferritin (HP:0003281) | 2.00684710 |
| 84 | Pathologic fracture (HP:0002756) | 2.00298903 |
| 85 | Slender build (HP:0001533) | 2.00165316 |
| 86 | Personality changes (HP:0000751) | 1.99119775 |
| 87 | Bone cyst (HP:0012062) | 1.98810842 |
| 88 | Hepatosplenomegaly (HP:0001433) | 1.98153952 |
| 89 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97586486 |
| 90 | Neuronal loss in central nervous system (HP:0002529) | 1.97547624 |
| 91 | Asymmetry of the thorax (HP:0001555) | 1.97192306 |
| 92 | Joint laxity (HP:0001388) | 1.97103332 |
| 93 | Wormian bones (HP:0002645) | 1.96792602 |
| 94 | Hyperextensible skin (HP:0000974) | 1.95575891 |
| 95 | Optic neuritis (HP:0100653) | 1.94821392 |
| 96 | Retrobulbar optic neuritis (HP:0100654) | 1.94821392 |
| 97 | Xanthomatosis (HP:0000991) | 1.93846406 |
| 98 | Conjunctival telangiectasia (HP:0000524) | 1.92386132 |
| 99 | Cardiomegaly (HP:0001640) | 1.92130826 |
| 100 | Esophageal varix (HP:0002040) | 1.91696493 |
| 101 | Aneurysm (HP:0002617) | 1.90145152 |
| 102 | Recurrent skin infections (HP:0001581) | 1.88454248 |
| 103 | Ulnar bowing (HP:0003031) | 1.87575106 |
| 104 | Progressive visual loss (HP:0000529) | 1.87373970 |
| 105 | Coarse hair (HP:0002208) | 1.85188282 |
| 106 | Spinal rigidity (HP:0003306) | 1.84403226 |
| 107 | Pulmonary infiltrates (HP:0002113) | 1.84214208 |
| 108 | Nonimmune hydrops fetalis (HP:0001790) | 1.84140931 |
| 109 | Short 4th metacarpal (HP:0010044) | 1.83721941 |
| 110 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.83721941 |
| 111 | Abnormality of the peritoneum (HP:0002585) | 1.83315106 |
| 112 | Skin nodule (HP:0200036) | 1.82937573 |
| 113 | Thick nail (HP:0001805) | 1.80590375 |
| 114 | Thin bony cortex (HP:0002753) | 1.80275292 |
| 115 | Camptodactyly of toe (HP:0001836) | 1.78978743 |
| 116 | Nephritis (HP:0000123) | 1.78771097 |
| 117 | Abnormality of the acetabulum (HP:0003170) | 1.78764617 |
| 118 | Asymmetric septal hypertrophy (HP:0001670) | 1.78024364 |
| 119 | Inappropriate behavior (HP:0000719) | 1.77678816 |
| 120 | Basal ganglia calcification (HP:0002135) | 1.77602297 |
| 121 | Protuberant abdomen (HP:0001538) | 1.77414109 |
| 122 | Myositis (HP:0100614) | 1.77294895 |
| 123 | Type 1 muscle fiber predominance (HP:0003803) | 1.77256487 |
| 124 | Biconcave vertebral bodies (HP:0004586) | 1.76986692 |
| 125 | Thoracic kyphosis (HP:0002942) | 1.76376791 |
| 126 | Prolonged neonatal jaundice (HP:0006579) | 1.75949603 |
| 127 | Malnutrition (HP:0004395) | 1.75736389 |
| 128 | Upper motor neuron abnormality (HP:0002127) | 1.75702550 |
| 129 | Bone pain (HP:0002653) | 1.73581692 |
| 130 | Apathy (HP:0000741) | 1.73439168 |
| 131 | Syringomyelia (HP:0003396) | 1.72244833 |
| 132 | Spinal cord lesions (HP:0100561) | 1.72244833 |
| 133 | Diminished motivation (HP:0000745) | 1.72231875 |
| 134 | Petechiae (HP:0000967) | 1.70617183 |
| 135 | Deviation of the hallux (HP:0010051) | 1.70464033 |
| 136 | Polyneuropathy (HP:0001271) | 1.69412430 |
| 137 | Femoral bowing (HP:0002980) | 1.69130139 |
| 138 | Retinal atrophy (HP:0001105) | 1.68822222 |
| 139 | Beaking of vertebral bodies (HP:0004568) | 1.67837994 |
| 140 | Turricephaly (HP:0000262) | 1.66854709 |
| 141 | Chronic obstructive pulmonary disease (HP:0006510) | 1.66067161 |
| 142 | Obstructive lung disease (HP:0006536) | 1.66067161 |
| 143 | Esophageal neoplasm (HP:0100751) | 1.61695283 |
| 144 | Neoplasm of head and neck (HP:0012288) | 1.61695283 |
| 145 | Premature loss of primary teeth (HP:0006323) | 1.60735047 |
| 146 | Mucosal telangiectasiae (HP:0100579) | 1.60609766 |
| 147 | Multiple enchondromatosis (HP:0005701) | 1.58104709 |
| 148 | Nausea (HP:0002018) | 1.57937883 |
| 149 | Abnormality of iron homeostasis (HP:0011031) | 1.56819851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.94274446 |
| 2 | TRIB3 | 3.69813495 |
| 3 | CAMK1D | 3.24713642 |
| 4 | NME2 | 3.19761756 |
| 5 | GRK7 | 3.15606020 |
| 6 | ACVR1B | 2.89702486 |
| 7 | KIT | 2.83337548 |
| 8 | MAP3K14 | 2.68449286 |
| 9 | DDR2 | 2.60241885 |
| 10 | CAMK1G | 2.46944633 |
| 11 | PKN2 | 2.37806492 |
| 12 | ERN1 | 2.36301141 |
| 13 | PDGFRA | 2.35623244 |
| 14 | EPHB1 | 2.30065209 |
| 15 | PAK4 | 2.19594653 |
| 16 | TTN | 2.06763013 |
| 17 | FES | 2.02448349 |
| 18 | RIPK1 | 2.01287900 |
| 19 | SIK1 | 2.00001126 |
| 20 | PRPF4B | 1.96524747 |
| 21 | NEK9 | 1.92046136 |
| 22 | PTK6 | 1.88974106 |
| 23 | TBK1 | 1.76406050 |
| 24 | PDGFRB | 1.76306854 |
| 25 | CDC42BPA | 1.69702035 |
| 26 | CSF1R | 1.69117572 |
| 27 | SCYL2 | 1.62876131 |
| 28 | PDK2 | 1.62472863 |
| 29 | LATS1 | 1.52493159 |
| 30 | CAMKK2 | 1.49274098 |
| 31 | MAP3K13 | 1.42979579 |
| 32 | KDR | 1.34854470 |
| 33 | TYRO3 | 1.32485834 |
| 34 | JAK1 | 1.32261154 |
| 35 | PAK2 | 1.31051385 |
| 36 | EPHB2 | 1.24605853 |
| 37 | CSK | 1.23451053 |
| 38 | EPHA3 | 1.21261920 |
| 39 | ABL2 | 1.21170843 |
| 40 | CDK6 | 1.18881470 |
| 41 | MAP2K3 | 1.18408162 |
| 42 | MAP3K11 | 1.17604723 |
| 43 | ZAP70 | 1.17603399 |
| 44 | TRPM7 | 1.17469171 |
| 45 | STK24 | 1.16015196 |
| 46 | RIPK4 | 1.14777805 |
| 47 | BMX | 1.12421282 |
| 48 | TYK2 | 1.09657621 |
| 49 | PTK2 | 1.03453420 |
| 50 | FGR | 1.01703984 |
| 51 | PBK | 0.97976764 |
| 52 | BMPR2 | 0.96610474 |
| 53 | ADRBK2 | 0.94236571 |
| 54 | KSR2 | 0.93544776 |
| 55 | STK3 | 0.93083743 |
| 56 | IKBKE | 0.92692961 |
| 57 | RET | 0.91460896 |
| 58 | TAOK1 | 0.90603077 |
| 59 | LRRK2 | 0.89628839 |
| 60 | MOS | 0.89311803 |
| 61 | IRAK4 | 0.88473629 |
| 62 | PTK2B | 0.87961508 |
| 63 | TIE1 | 0.87915234 |
| 64 | MAP3K1 | 0.87535972 |
| 65 | CAMKK1 | 0.87494651 |
| 66 | HCK | 0.85874255 |
| 67 | IRAK2 | 0.83401752 |
| 68 | IRAK3 | 0.82901067 |
| 69 | MET | 0.82610626 |
| 70 | INSR | 0.78614087 |
| 71 | ERBB4 | 0.78491664 |
| 72 | MAP3K3 | 0.78222680 |
| 73 | CHUK | 0.78150424 |
| 74 | LATS2 | 0.78075270 |
| 75 | STK10 | 0.76264051 |
| 76 | MAP3K2 | 0.75940407 |
| 77 | MATK | 0.74306120 |
| 78 | PRKCH | 0.72246472 |
| 79 | FRK | 0.72223946 |
| 80 | IGF1R | 0.71074140 |
| 81 | JAK2 | 0.70778345 |
| 82 | MAP3K5 | 0.70685706 |
| 83 | PIK3CA | 0.69604383 |
| 84 | SRC | 0.68806539 |
| 85 | GSK3A | 0.67215123 |
| 86 | DMPK | 0.66484301 |
| 87 | CDK9 | 0.66068073 |
| 88 | ICK | 0.64762116 |
| 89 | NUAK1 | 0.64693960 |
| 90 | IRAK1 | 0.64419917 |
| 91 | STK38L | 0.63744125 |
| 92 | RPS6KA4 | 0.63471166 |
| 93 | ABL1 | 0.63422717 |
| 94 | FGFR3 | 0.63228321 |
| 95 | EGFR | 0.62630139 |
| 96 | LMTK2 | 0.62227175 |
| 97 | TGFBR1 | 0.62024735 |
| 98 | JAK3 | 0.62010519 |
| 99 | MAPK7 | 0.61948449 |
| 100 | MST1R | 0.61540684 |
| 101 | LYN | 0.59240301 |
| 102 | PDPK1 | 0.57255049 |
| 103 | FER | 0.57132396 |
| 104 | LCK | 0.56548700 |
| 105 | TESK1 | 0.56179224 |
| 106 | FYN | 0.55718422 |
| 107 | ARAF | 0.55058815 |
| 108 | TAOK2 | 0.53906021 |
| 109 | MAP2K1 | 0.53547167 |
| 110 | SYK | 0.52952345 |
| 111 | RPS6KA2 | 0.51756500 |
| 112 | MARK3 | 0.51202280 |
| 113 | MTOR | 0.51144673 |
| 114 | FGFR2 | 0.51139013 |
| 115 | ITK | 0.48263800 |
| 116 | MAP4K1 | 0.47609273 |
| 117 | MELK | 0.46401639 |
| 118 | LIMK1 | 0.45948675 |
| 119 | BMPR1B | 0.45522033 |
| 120 | TESK2 | 0.45485705 |
| 121 | RPS6KL1 | 0.44810880 |
| 122 | RPS6KC1 | 0.44810880 |
| 123 | ILK | 0.44522016 |
| 124 | IKBKB | 0.44442470 |
| 125 | BLK | 0.42495666 |
| 126 | PRKG2 | 0.42159493 |
| 127 | PIM2 | 0.41823090 |
| 128 | ROCK1 | 0.41669235 |
| 129 | PRKAA2 | 0.41625264 |
| 130 | NTRK1 | 0.41168898 |
| 131 | KSR1 | 0.40303763 |
| 132 | FGFR1 | 0.40270688 |
| 133 | ERBB2 | 0.39882919 |
| 134 | ERBB3 | 0.39357882 |
| 135 | PDK1 | 0.39002855 |
| 136 | MAP3K8 | 0.38813308 |
| 137 | SGK3 | 0.37336694 |
| 138 | FGFR4 | 0.37202037 |
| 139 | MAPK12 | 0.35510527 |
| 140 | MAPK4 | 0.34429716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.68569160 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.29710764 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.74246074 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16836909 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.14771653 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.95883625 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95549003 |
| 8 | Malaria_Homo sapiens_hsa05144 | 1.90649481 |
| 9 | Phagosome_Homo sapiens_hsa04145 | 1.84224970 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.81327019 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79417482 |
| 12 | Asthma_Homo sapiens_hsa05310 | 1.75119428 |
| 13 | Focal adhesion_Homo sapiens_hsa04510 | 1.73759483 |
| 14 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.69304795 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 1.67583690 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.56085383 |
| 17 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.55599762 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.54606195 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54309981 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52553680 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51240829 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.46713144 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.45343478 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.44496842 |
| 25 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43595453 |
| 26 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.41121404 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.36101855 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32156477 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30675887 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29848996 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29278941 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.28164616 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.27943729 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25377028 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20933641 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.20169268 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12441391 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.08984131 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08429234 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06307908 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.03944900 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03209539 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.03053212 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.02524307 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.02386214 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.00186995 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98046426 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97762984 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97394636 |
| 50 | Glioma_Homo sapiens_hsa05214 | 0.96800851 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.95432243 |
| 52 | Melanoma_Homo sapiens_hsa05218 | 0.95001242 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94682583 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94045517 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92472372 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92318617 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92163916 |
| 58 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92106718 |
| 59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.91649779 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90576534 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90388762 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89679700 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.89650847 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.89428895 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88016766 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.85952442 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84675484 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82226236 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81043180 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81024476 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.80667013 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80402675 |
| 73 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.80120987 |
| 74 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.79411019 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.78309341 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.78035820 |
| 77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77358807 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.76605160 |
| 79 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74550666 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73711910 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73200216 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73154368 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70976336 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.70585792 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69146549 |
| 86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66660522 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66549762 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66266480 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66128020 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.65310949 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65256004 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63546659 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62547150 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.61947457 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61020186 |
| 96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60518958 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59830408 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58843239 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58579120 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56630756 |
| 101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55221850 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.54864023 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53798585 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52943144 |
| 105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52594026 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52022886 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.50866548 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.50655912 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49763186 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49111066 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.48987228 |
| 112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48904391 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47440228 |
| 114 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.47127797 |
| 115 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43802598 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39647155 |
| 117 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.37737131 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33200856 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32118552 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30103692 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29969764 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29962697 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26175532 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25392467 |

